Guardant Health - Health Technology Insights

Enveric Biosciences Identifies Neuroplastogen Candidates for Disease

May 20, 2025
HealthTech Media Room
Cancer, Genomics and Precision Medicine, HealthTech News

Guardant Health Launches Hereditary Cancer Testing for Risks

New Guardant Hereditary Cancer test offers germline testing to identify guideline-recommended genetic variants associated with cancer risk across 12+ tumor types Guardant Health, , a leading precision oncology company,...

April 28, 2025
HealthTech Media Room
Biotechnology, Cancer, Diagnostics and Devices, HealthTech News, Lab Diagnostics

Guardant Health Launches Guardant360 Tissue, Offering Complete Cancer View with Multiomic Analysis

Powered by Guardant Infinity smart liquid biopsy platform, advanced multiomic test evaluates genomic, epigenomic and RNA-based molecular data Guardant Health, Inc. , a leading precision oncology company, announced the...

April 22, 2025
HealthTech Media Room
Cancer, Healthcare Data Management, HealthTech News, Software & Data

Guardant Health to Present Advances in Multi-Cancer Detection at AACR

Four oral sessions to be presented, including validation data for Shield MCD test, selected for highly anticipated NCI Vanguard Study Guardant Health, Inc. a leading precision oncology company, announced...

Fuel up with free Health Tech Insights

Guardant Health Launches Hereditary Cancer Testing for Risks

Guardant Health Launches Guardant360 Tissue, Offering Complete Cancer View with Multiomic Analysis

Guardant Health to Present Advances in Multi-Cancer Detection at AACR

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands